Concepedia

Mathias Liljeblad

ML

11

Publications

260

Citations

11

H-Index

1998

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Linköping University

Landstinget i Kalmar län

Ionis Pharmaceuticals (United States)

AstraZeneca (United States)

Mathias Liljeblad is an author at AstraZeneca (Sweden) specializing in medicine, bioanalysis, and immunology.

ORCID

Top concepts

Publications per year

1998–2025

11

Publications

11

Determination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry

Ia Hultman, Helene Stenhoff, Mathias Liljeblad · Journal of Chromatography B · 2006 · 41 citations

, , +11

Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice

Stefano Bartesaghi, Kristina Wallenius, Daniel Hovdal et al. · Molecular Therapy — Nucleic Acids · 2022 · 36 citations · Full text

AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials

Javier Armisen, Mitra Rauschecker, Janeli Sarv et al. · Journal of Hepatology · 2025 · 32 citations

, , +8

Analysis of glycoproteins in cell culture supernatants using a lectin immunosensor technique

Mathias Liljeblad, Arne Lundblad, Peter Påhlsson · Biosensors and Bioelectronics · 2002 · 24 citations

, , +11

Analysis of agalacto-IgG in rheumatoid arthritis using surface plasmon resonance

Mathias Liljeblad, Arne Lundblad, Peter Påhlsson · Glycoconjugate Journal · 2000 · 22 citations

Rows per page

1–5 of 11